---
layout: post
title: "Scientific Challenges and Opportunities To Advance the Development of Individualized Cellular and Gene Therapies; Request for Information"
date: 2026-02-05 18:56:54 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-20452
original_published: 2023-09-21 00:00:00 +0000
significance: 8.00
---

# Scientific Challenges and Opportunities To Advance the Development of Individualized Cellular and Gene Therapies; Request for Information

**Published:** February 05, 2026 18:56 UTC
**Source:** Federal Register
**Original Published:** September 21, 2023 00:00 UTC
**Document Number:** 2023-20452

## Summary

The Food and Drug Administration (FDA or Agency), Center for Biologics Evaluation and Research (CBER) is requesting information from stakeholders regarding critical scientific challenges and opportunities to advance the development of individualized cellular and gene therapies (CGTs). FDA intends to gather information and comments submitted in response to this request for information (RFI) to inform potential planning of future town halls, workshops, or discussion papers which could ultimately facilitate the development of additional regulatory science tools, standards, or guidance.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/09/21/2023-20452/scientific-challenges-and-opportunities-to-advance-the-development-of-individualized-cellular-and)
- API: https://www.federalregister.gov/api/v1/documents/2023-20452

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
